<DOC>
	<DOC>NCT00797394</DOC>
	<brief_summary>The purpose of this study is to determine if the combination of 2007RD01, a natural extract, and saw palmetto lipidic extract, is more effective at treating lower urinary tract symptoms associated with benign prostatic hyperplasia than saw palmetto lipidic extract alone.</brief_summary>
	<brief_title>Efficacy of Natural Extract 2007RD01 Combined With Saw Palmetto in Benign Prostatic Hyperplasia Patients Compared to Saw Palmetto</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Permixon</mesh_term>
	<criteria>Patient must be an adult man aged between 50 and 75 Patient must have Benign Prostatic Hyperplasia symptoms Patient has a malfunction of the urinary tract, is suffering from acute urinary retention, or is suffering from prostate cancer or urinary tract infection Patient has been subjected to surgery of the prostate, bladder or urethra Patient has taken a 5alphareductase inhibitor in the 6month period preceding screening Patient has taken an alphablocker in the 2week period preceding screening</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>prostate</keyword>
	<keyword>dietary supplements</keyword>
	<keyword>saw palmetto</keyword>
	<keyword>canada</keyword>
</DOC>